Molecular drug susceptibility testing against the first-line (rifampin and isoniazid) and second-line (ciprofloxacin–amikacin and kanamycin) treatment in different subtypes of Mycobacterium simiae

Molecular drug susceptibility testing against the first-line (rifampin and isoniazid) and second-line (ciprofloxacin–amikacin and kanamycin) treatment in different subtypes of Mycobacterium simiae

Objective background: Mycobacterium simiae has been identified as the most prevalent slow growing mycobacteria that has been isolated among Iranian patients. Due to an importance of molecular approaches in the treatment of nontuberculosis mycobacteria, this study aimed to evaluate molecular drug sus...

Full description

Bibliographic Details
Main Authors: Parissa Farnia, Donya Malekshahian, Payam Tabarsi, Shima Seif, Ali Akbar Velayati
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2016-01-01
Series:International Journal of Mycobacteriology
Subjects:
Amikacin
Ciprofloxacin
Isoniazid
Kanamycin
Molecular drug susceptibility testing
Mycobacterium simiae
Rifampin
Online Access:http://www.ijmyco.org/article.asp?issn=2212-5531;year=2016;volume=5;issue=5;spage=215;epage=215;aulast=Farnia

Internet

http://www.ijmyco.org/article.asp?issn=2212-5531;year=2016;volume=5;issue=5;spage=215;epage=215;aulast=Farnia

Similar Items